The global market for Antiviral Biomaterials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Antiviral Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antiviral Biomaterials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antiviral Biomaterials include Arkema, Bayer, Showa Denko, DowDuPont, Ahlstrom, Hollingsworth & Vose, Kuraray, Finetex, Elmarco, Nanocyl, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiviral Biomaterials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Biomaterials.

The Antiviral Biomaterials market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Biomaterials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiviral Biomaterials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antiviral Biomaterials Market Report

Report Metric	Details
Report Name	Antiviral Biomaterials Market
by Type	Metal Carbon Nanomaterial Graphene and Its Derivatives
by Application	Construction Automotive Consumer Goods Textile Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Arkema, Bayer, Showa Denko, DowDuPont, Ahlstrom, Hollingsworth & Vose, Kuraray, Finetex, Elmarco, Nanocyl, CNano Technology, Hyperion Catalysis, Thomas Swan, NanoXplore, TECHINSTRO, XG Sciences, NorGraphene Technologies, Graphmatech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiviral Biomaterials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Antiviral Biomaterials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Antiviral Biomaterials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antiviral Biomaterials Market report?

Ans: The main players in the Antiviral Biomaterials Market are Arkema, Bayer, Showa Denko, DowDuPont, Ahlstrom, Hollingsworth & Vose, Kuraray, Finetex, Elmarco, Nanocyl, CNano Technology, Hyperion Catalysis, Thomas Swan, NanoXplore, TECHINSTRO, XG Sciences, NorGraphene Technologies, Graphmatech

What are the Application segmentation covered in the Antiviral Biomaterials Market report?

Ans: The Applications covered in the Antiviral Biomaterials Market report are Construction, Automotive, Consumer Goods, Textile, Others

What are the Type segmentation covered in the Antiviral Biomaterials Market report?

Ans: The Types covered in the Antiviral Biomaterials Market report are Metal, Carbon Nanomaterial, Graphene and Its Derivatives

1 Antiviral Biomaterials Market Overview

1.1 Product Definition

1.2 Antiviral Biomaterials by Type

1.2.1 Global Antiviral Biomaterials Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Metal

1.2.3 Carbon Nanomaterial

1.2.4 Graphene and Its Derivatives

1.3 Antiviral Biomaterials by Application

1.3.1 Global Antiviral Biomaterials Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Construction

1.3.3 Automotive

1.3.4 Consumer Goods

1.3.5 Textile

1.3.6 Others

1.4 Global Market Growth Prospects

1.4.1 Global Antiviral Biomaterials Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Antiviral Biomaterials Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Antiviral Biomaterials Production Estimates and Forecasts (2020-2031)

1.4.4 Global Antiviral Biomaterials Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Antiviral Biomaterials Production Market Share by Manufacturers (2020-2025)

2.2 Global Antiviral Biomaterials Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Antiviral Biomaterials, Industry Ranking, 2023 VS 2024

2.4 Global Antiviral Biomaterials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Antiviral Biomaterials Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Antiviral Biomaterials, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Antiviral Biomaterials, Product Offered and Application

2.8 Global Key Manufacturers of Antiviral Biomaterials, Date of Enter into This Industry

2.9 Antiviral Biomaterials Market Competitive Situation and Trends

2.9.1 Antiviral Biomaterials Market Concentration Rate

2.9.2 Global 5 and 10 Largest Antiviral Biomaterials Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Antiviral Biomaterials Production by Region

3.1 Global Antiviral Biomaterials Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Antiviral Biomaterials Production Value by Region (2020-2031)

3.2.1 Global Antiviral Biomaterials Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Antiviral Biomaterials by Region (2026-2031)

3.3 Global Antiviral Biomaterials Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Antiviral Biomaterials Production Volume by Region (2020-2031)

3.4.1 Global Antiviral Biomaterials Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Antiviral Biomaterials by Region (2026-2031)

3.5 Global Antiviral Biomaterials Market Price Analysis by Region (2020-2025)

3.6 Global Antiviral Biomaterials Production and Value, Year-over-Year Growth

3.6.1 North America Antiviral Biomaterials Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Antiviral Biomaterials Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Antiviral Biomaterials Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Antiviral Biomaterials Production Value Estimates and Forecasts (2020-2031)

4 Antiviral Biomaterials Consumption by Region

4.1 Global Antiviral Biomaterials Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Antiviral Biomaterials Consumption by Region (2020-2031)

4.2.1 Global Antiviral Biomaterials Consumption by Region (2020-2025)

4.2.2 Global Antiviral Biomaterials Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Antiviral Biomaterials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Antiviral Biomaterials Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Antiviral Biomaterials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Antiviral Biomaterials Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Antiviral Biomaterials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Antiviral Biomaterials Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Antiviral Biomaterials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Antiviral Biomaterials Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Antiviral Biomaterials Production by Type (2020-2031)

5.1.1 Global Antiviral Biomaterials Production by Type (2020-2025)

5.1.2 Global Antiviral Biomaterials Production by Type (2026-2031)

5.1.3 Global Antiviral Biomaterials Production Market Share by Type (2020-2031)

5.2 Global Antiviral Biomaterials Production Value by Type (2020-2031)

5.2.1 Global Antiviral Biomaterials Production Value by Type (2020-2025)

5.2.2 Global Antiviral Biomaterials Production Value by Type (2026-2031)

5.2.3 Global Antiviral Biomaterials Production Value Market Share by Type (2020-2031)

5.3 Global Antiviral Biomaterials Price by Type (2020-2031)

6 Segment by Application

6.1 Global Antiviral Biomaterials Production by Application (2020-2031)

6.1.1 Global Antiviral Biomaterials Production by Application (2020-2025)

6.1.2 Global Antiviral Biomaterials Production by Application (2026-2031)

6.1.3 Global Antiviral Biomaterials Production Market Share by Application (2020-2031)

6.2 Global Antiviral Biomaterials Production Value by Application (2020-2031)

6.2.1 Global Antiviral Biomaterials Production Value by Application (2020-2025)

6.2.2 Global Antiviral Biomaterials Production Value by Application (2026-2031)

6.2.3 Global Antiviral Biomaterials Production Value Market Share by Application (2020-2031)

6.3 Global Antiviral Biomaterials Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Arkema

7.1.1 Arkema Antiviral Biomaterials Company Information

7.1.2 Arkema Antiviral Biomaterials Product Portfolio

7.1.3 Arkema Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Arkema Main Business and Markets Served

7.1.5 Arkema Recent Developments/Updates

7.2 Bayer

7.2.1 Bayer Antiviral Biomaterials Company Information

7.2.2 Bayer Antiviral Biomaterials Product Portfolio

7.2.3 Bayer Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Bayer Main Business and Markets Served

7.2.5 Bayer Recent Developments/Updates

7.3 Showa Denko

7.3.1 Showa Denko Antiviral Biomaterials Company Information

7.3.2 Showa Denko Antiviral Biomaterials Product Portfolio

7.3.3 Showa Denko Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Showa Denko Main Business and Markets Served

7.3.5 Showa Denko Recent Developments/Updates

7.4 DowDuPont

7.4.1 DowDuPont Antiviral Biomaterials Company Information

7.4.2 DowDuPont Antiviral Biomaterials Product Portfolio

7.4.3 DowDuPont Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.4.4 DowDuPont Main Business and Markets Served

7.4.5 DowDuPont Recent Developments/Updates

7.5 Ahlstrom

7.5.1 Ahlstrom Antiviral Biomaterials Company Information

7.5.2 Ahlstrom Antiviral Biomaterials Product Portfolio

7.5.3 Ahlstrom Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Ahlstrom Main Business and Markets Served

7.5.5 Ahlstrom Recent Developments/Updates

7.6 Hollingsworth & Vose

7.6.1 Hollingsworth & Vose Antiviral Biomaterials Company Information

7.6.2 Hollingsworth & Vose Antiviral Biomaterials Product Portfolio

7.6.3 Hollingsworth & Vose Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Hollingsworth & Vose Main Business and Markets Served

7.6.5 Hollingsworth & Vose Recent Developments/Updates

7.7 Kuraray

7.7.1 Kuraray Antiviral Biomaterials Company Information

7.7.2 Kuraray Antiviral Biomaterials Product Portfolio

7.7.3 Kuraray Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Kuraray Main Business and Markets Served

7.7.5 Kuraray Recent Developments/Updates

7.8 Finetex

7.8.1 Finetex Antiviral Biomaterials Company Information

7.8.2 Finetex Antiviral Biomaterials Product Portfolio

7.8.3 Finetex Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Finetex Main Business and Markets Served

7.8.5 Finetex Recent Developments/Updates

7.9 Elmarco

7.9.1 Elmarco Antiviral Biomaterials Company Information

7.9.2 Elmarco Antiviral Biomaterials Product Portfolio

7.9.3 Elmarco Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Elmarco Main Business and Markets Served

7.9.5 Elmarco Recent Developments/Updates

7.10 Nanocyl

7.10.1 Nanocyl Antiviral Biomaterials Company Information

7.10.2 Nanocyl Antiviral Biomaterials Product Portfolio

7.10.3 Nanocyl Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Nanocyl Main Business and Markets Served

7.10.5 Nanocyl Recent Developments/Updates

7.11 CNano Technology

7.11.1 CNano Technology Antiviral Biomaterials Company Information

7.11.2 CNano Technology Antiviral Biomaterials Product Portfolio

7.11.3 CNano Technology Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.11.4 CNano Technology Main Business and Markets Served

7.11.5 CNano Technology Recent Developments/Updates

7.12 Hyperion Catalysis

7.12.1 Hyperion Catalysis Antiviral Biomaterials Company Information

7.12.2 Hyperion Catalysis Antiviral Biomaterials Product Portfolio

7.12.3 Hyperion Catalysis Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Hyperion Catalysis Main Business and Markets Served

7.12.5 Hyperion Catalysis Recent Developments/Updates

7.13 Thomas Swan

7.13.1 Thomas Swan Antiviral Biomaterials Company Information

7.13.2 Thomas Swan Antiviral Biomaterials Product Portfolio

7.13.3 Thomas Swan Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Thomas Swan Main Business and Markets Served

7.13.5 Thomas Swan Recent Developments/Updates

7.14 NanoXplore

7.14.1 NanoXplore Antiviral Biomaterials Company Information

7.14.2 NanoXplore Antiviral Biomaterials Product Portfolio

7.14.3 NanoXplore Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.14.4 NanoXplore Main Business and Markets Served

7.14.5 NanoXplore Recent Developments/Updates

7.15 TECHINSTRO

7.15.1 TECHINSTRO Antiviral Biomaterials Company Information

7.15.2 TECHINSTRO Antiviral Biomaterials Product Portfolio

7.15.3 TECHINSTRO Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.15.4 TECHINSTRO Main Business and Markets Served

7.15.5 TECHINSTRO Recent Developments/Updates

7.16 XG Sciences

7.16.1 XG Sciences Antiviral Biomaterials Company Information

7.16.2 XG Sciences Antiviral Biomaterials Product Portfolio

7.16.3 XG Sciences Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.16.4 XG Sciences Main Business and Markets Served

7.16.5 XG Sciences Recent Developments/Updates

7.17 NorGraphene Technologies

7.17.1 NorGraphene Technologies Antiviral Biomaterials Company Information

7.17.2 NorGraphene Technologies Antiviral Biomaterials Product Portfolio

7.17.3 NorGraphene Technologies Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.17.4 NorGraphene Technologies Main Business and Markets Served

7.17.5 NorGraphene Technologies Recent Developments/Updates

7.18 Graphmatech

7.18.1 Graphmatech Antiviral Biomaterials Company Information

7.18.2 Graphmatech Antiviral Biomaterials Product Portfolio

7.18.3 Graphmatech Antiviral Biomaterials Production, Value, Price and Gross Margin (2020-2025)

7.18.4 Graphmatech Main Business and Markets Served

7.18.5 Graphmatech Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Antiviral Biomaterials Industry Chain Analysis

8.2 Antiviral Biomaterials Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Antiviral Biomaterials Production Mode & Process Analysis

8.4 Antiviral Biomaterials Sales and Marketing

8.4.1 Antiviral Biomaterials Sales Channels

8.4.2 Antiviral Biomaterials Distributors

8.5 Antiviral Biomaterials Customer Analysis

9 Antiviral Biomaterials Market Dynamics

9.1 Antiviral Biomaterials Industry Trends

9.2 Antiviral Biomaterials Market Drivers

9.3 Antiviral Biomaterials Market Challenges

9.4 Antiviral Biomaterials Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

NorGraphene Technologies

Graphmatech

List of Tables

Table 1. Global Antiviral Biomaterials Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Antiviral Biomaterials Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Antiviral Biomaterials Production Capacity (K MT) by Manufacturers in 2024

Table 4. Global Antiviral Biomaterials Production by Manufacturers (2020-2025) & (K MT)

Table 5. Global Antiviral Biomaterials Production Market Share by Manufacturers (2020-2025)

Table 6. Global Antiviral Biomaterials Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Antiviral Biomaterials Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Antiviral Biomaterials, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Antiviral Biomaterials as of 2024)

Table 10. Global Market Antiviral Biomaterials Average Price by Manufacturers (USD/MT) & (2020-2025)

Table 11. Global Key Manufacturers of Antiviral Biomaterials, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Antiviral Biomaterials, Product Offered and Application

Table 13. Global Key Manufacturers of Antiviral Biomaterials, Date of Enter into This Industry

Table 14. Global Antiviral Biomaterials Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiviral Biomaterials Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Antiviral Biomaterials Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Antiviral Biomaterials Production Value Market Share by Region (2020-2025)

Table 19. Global Antiviral Biomaterials Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Antiviral Biomaterials Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Antiviral Biomaterials Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)

Table 22. Global Antiviral Biomaterials Production (K MT) by Region (2020-2025)

Table 23. Global Antiviral Biomaterials Production Market Share by Region (2020-2025)

Table 24. Global Antiviral Biomaterials Production (K MT) Forecast by Region (2026-2031)

Table 25. Global Antiviral Biomaterials Production Market Share Forecast by Region (2026-2031)

Table 26. Global Antiviral Biomaterials Market Average Price (USD/MT) by Region (2020-2025)

Table 27. Global Antiviral Biomaterials Market Average Price (USD/MT) by Region (2026-2031)

Table 28. Global Antiviral Biomaterials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)

Table 29. Global Antiviral Biomaterials Consumption by Region (2020-2025) & (K MT)

Table 30. Global Antiviral Biomaterials Consumption Market Share by Region (2020-2025)

Table 31. Global Antiviral Biomaterials Forecasted Consumption by Region (2026-2031) & (K MT)

Table 32. Global Antiviral Biomaterials Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Antiviral Biomaterials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)

Table 34. North America Antiviral Biomaterials Consumption by Country (2020-2025) & (K MT)

Table 35. North America Antiviral Biomaterials Consumption by Country (2026-2031) & (K MT)

Table 36. Europe Antiviral Biomaterials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)

Table 37. Europe Antiviral Biomaterials Consumption by Country (2020-2025) & (K MT)

Table 38. Europe Antiviral Biomaterials Consumption by Country (2026-2031) & (K MT)

Table 39. Asia Pacific Antiviral Biomaterials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)

Table 40. Asia Pacific Antiviral Biomaterials Consumption by Region (2020-2025) & (K MT)

Table 41. Asia Pacific Antiviral Biomaterials Consumption by Region (2026-2031) & (K MT)

Table 42. Latin America, Middle East & Africa Antiviral Biomaterials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)

Table 43. Latin America, Middle East & Africa Antiviral Biomaterials Consumption by Country (2020-2025) & (K MT)

Table 44. Latin America, Middle East & Africa Antiviral Biomaterials Consumption by Country (2026-2031) & (K MT)

Table 45. Global Antiviral Biomaterials Production (K MT) by Type (2020-2025)

Table 46. Global Antiviral Biomaterials Production (K MT) by Type (2026-2031)

Table 47. Global Antiviral Biomaterials Production Market Share by Type (2020-2025)

Table 48. Global Antiviral Biomaterials Production Market Share by Type (2026-2031)

Table 49. Global Antiviral Biomaterials Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Antiviral Biomaterials Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Antiviral Biomaterials Production Value Market Share by Type (2020-2025)

Table 52. Global Antiviral Biomaterials Production Value Market Share by Type (2026-2031)

Table 53. Global Antiviral Biomaterials Price (USD/MT) by Type (2020-2025)

Table 54. Global Antiviral Biomaterials Price (USD/MT) by Type (2026-2031)

Table 55. Global Antiviral Biomaterials Production (K MT) by Application (2020-2025)

Table 56. Global Antiviral Biomaterials Production (K MT) by Application (2026-2031)

Table 57. Global Antiviral Biomaterials Production Market Share by Application (2020-2025)

Table 58. Global Antiviral Biomaterials Production Market Share by Application (2026-2031)

Table 59. Global Antiviral Biomaterials Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Antiviral Biomaterials Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Antiviral Biomaterials Production Value Market Share by Application (2020-2025)

Table 62. Global Antiviral Biomaterials Production Value Market Share by Application (2026-2031)

Table 63. Global Antiviral Biomaterials Price (USD/MT) by Application (2020-2025)

Table 64. Global Antiviral Biomaterials Price (USD/MT) by Application (2026-2031)

Table 65. Arkema Antiviral Biomaterials Company Information

Table 66. Arkema Antiviral Biomaterials Specification and Application

Table 67. Arkema Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 68. Arkema Main Business and Markets Served

Table 69. Arkema Recent Developments/Updates

Table 70. Bayer Antiviral Biomaterials Company Information

Table 71. Bayer Antiviral Biomaterials Specification and Application

Table 72. Bayer Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Bayer Main Business and Markets Served

Table 74. Bayer Recent Developments/Updates

Table 75. Showa Denko Antiviral Biomaterials Company Information

Table 76. Showa Denko Antiviral Biomaterials Specification and Application

Table 77. Showa Denko Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Showa Denko Main Business and Markets Served

Table 79. Showa Denko Recent Developments/Updates

Table 80. DowDuPont Antiviral Biomaterials Company Information

Table 81. DowDuPont Antiviral Biomaterials Specification and Application

Table 82. DowDuPont Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. DowDuPont Main Business and Markets Served

Table 84. DowDuPont Recent Developments/Updates

Table 85. Ahlstrom Antiviral Biomaterials Company Information

Table 86. Ahlstrom Antiviral Biomaterials Specification and Application

Table 87. Ahlstrom Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. Ahlstrom Main Business and Markets Served

Table 89. Ahlstrom Recent Developments/Updates

Table 90. Hollingsworth & Vose Antiviral Biomaterials Company Information

Table 91. Hollingsworth & Vose Antiviral Biomaterials Specification and Application

Table 92. Hollingsworth & Vose Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Hollingsworth & Vose Main Business and Markets Served

Table 94. Hollingsworth & Vose Recent Developments/Updates

Table 95. Kuraray Antiviral Biomaterials Company Information

Table 96. Kuraray Antiviral Biomaterials Specification and Application

Table 97. Kuraray Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Kuraray Main Business and Markets Served

Table 99. Kuraray Recent Developments/Updates

Table 100. Finetex Antiviral Biomaterials Company Information

Table 101. Finetex Antiviral Biomaterials Specification and Application

Table 102. Finetex Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Finetex Main Business and Markets Served

Table 104. Finetex Recent Developments/Updates

Table 105. Elmarco Antiviral Biomaterials Company Information

Table 106. Elmarco Antiviral Biomaterials Specification and Application

Table 107. Elmarco Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. Elmarco Main Business and Markets Served

Table 109. Elmarco Recent Developments/Updates

Table 110. Nanocyl Antiviral Biomaterials Company Information

Table 111. Nanocyl Antiviral Biomaterials Specification and Application

Table 112. Nanocyl Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. Nanocyl Main Business and Markets Served

Table 114. Nanocyl Recent Developments/Updates

Table 115. CNano Technology Antiviral Biomaterials Company Information

Table 116. CNano Technology Antiviral Biomaterials Specification and Application

Table 117. CNano Technology Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. CNano Technology Main Business and Markets Served

Table 119. CNano Technology Recent Developments/Updates

Table 120. Hyperion Catalysis Antiviral Biomaterials Company Information

Table 121. Hyperion Catalysis Antiviral Biomaterials Specification and Application

Table 122. Hyperion Catalysis Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 123. Hyperion Catalysis Main Business and Markets Served

Table 124. Hyperion Catalysis Recent Developments/Updates

Table 125. Thomas Swan Antiviral Biomaterials Company Information

Table 126. Thomas Swan Antiviral Biomaterials Specification and Application

Table 127. Thomas Swan Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 128. Thomas Swan Main Business and Markets Served

Table 129. Thomas Swan Recent Developments/Updates

Table 130. NanoXplore Antiviral Biomaterials Company Information

Table 131. NanoXplore Antiviral Biomaterials Specification and Application

Table 132. NanoXplore Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 133. NanoXplore Main Business and Markets Served

Table 134. NanoXplore Recent Developments/Updates

Table 135. TECHINSTRO Antiviral Biomaterials Company Information

Table 136. TECHINSTRO Antiviral Biomaterials Specification and Application

Table 137. TECHINSTRO Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 138. TECHINSTRO Main Business and Markets Served

Table 139. TECHINSTRO Recent Developments/Updates

Table 140. XG Sciences Antiviral Biomaterials Company Information

Table 141. XG Sciences Antiviral Biomaterials Specification and Application

Table 142. XG Sciences Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 143. XG Sciences Main Business and Markets Served

Table 144. XG Sciences Recent Developments/Updates

Table 145. NorGraphene Technologies Antiviral Biomaterials Company Information

Table 146. NorGraphene Technologies Antiviral Biomaterials Specification and Application

Table 147. NorGraphene Technologies Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 148. NorGraphene Technologies Main Business and Markets Served

Table 149. NorGraphene Technologies Recent Developments/Updates

Table 150. Graphmatech Antiviral Biomaterials Company Information

Table 151. Graphmatech Antiviral Biomaterials Specification and Application

Table 152. Graphmatech Antiviral Biomaterials Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 153. Graphmatech Main Business and Markets Served

Table 154. Graphmatech Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Antiviral Biomaterials Distributors List

Table 158. Antiviral Biomaterials Customers List

Table 159. Antiviral Biomaterials Market Trends

Table 160. Antiviral Biomaterials Market Drivers

Table 161. Antiviral Biomaterials Market Challenges

Table 162. Antiviral Biomaterials Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antiviral Biomaterials

Figure 2. Global Antiviral Biomaterials Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Antiviral Biomaterials Market Share by Type: 2024 VS 2031

Figure 4. Metal Product Picture

Figure 5. Carbon Nanomaterial Product Picture

Figure 6. Graphene and Its Derivatives Product Picture

Figure 7. Global Antiviral Biomaterials Market Value by Application, (US$ Million) & (2020-2031)

Figure 8. Global Antiviral Biomaterials Market Share by Application: 2024 VS 2031

Figure 9. Construction

Figure 10. Automotive

Figure 11. Consumer Goods

Figure 12. Textile

Figure 13. Others

Figure 14. Global Antiviral Biomaterials Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Antiviral Biomaterials Production Value (US$ Million) & (2020-2031)

Figure 16. Global Antiviral Biomaterials Production Capacity (K MT) & (2020-2031)

Figure 17. Global Antiviral Biomaterials Production (K MT) & (2020-2031)

Figure 18. Global Antiviral Biomaterials Average Price (USD/MT) & (2020-2031)

Figure 19. Antiviral Biomaterials Report Years Considered

Figure 20. Antiviral Biomaterials Production Share by Manufacturers in 2024

Figure 21. Global Antiviral Biomaterials Production Value Share by Manufacturers (2024)

Figure 22. Antiviral Biomaterials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. The Global 5 and 10 Largest Players: Market Share by Antiviral Biomaterials Revenue in 2024

Figure 24. Global Antiviral Biomaterials Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 25. Global Antiviral Biomaterials Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. Global Antiviral Biomaterials Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)

Figure 27. Global Antiviral Biomaterials Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 28. North America Antiviral Biomaterials Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Europe Antiviral Biomaterials Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. China Antiviral Biomaterials Production Value (US$ Million) Growth Rate (2020-2031)

Figure 31. Japan Antiviral Biomaterials Production Value (US$ Million) Growth Rate (2020-2031)

Figure 32. Global Antiviral Biomaterials Consumption by Region: 2020 VS 2024 VS 2031 (K MT)

Figure 33. Global Antiviral Biomaterials Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 34. North America Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 35. North America Antiviral Biomaterials Consumption Market Share by Country (2020-2031)

Figure 36. U.S. Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 37. Canada Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 38. Europe Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 39. Europe Antiviral Biomaterials Consumption Market Share by Country (2020-2031)

Figure 40. Germany Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 41. France Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 42. U.K. Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 43. Italy Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 44. Russia Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 45. Asia Pacific Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 46. Asia Pacific Antiviral Biomaterials Consumption Market Share by Region (2020-2031)

Figure 47. China Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 48. Japan Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 49. South Korea Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 50. China Taiwan Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 51. Southeast Asia Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 52. India Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 53. Latin America, Middle East & Africa Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 54. Latin America, Middle East & Africa Antiviral Biomaterials Consumption Market Share by Country (2020-2031)

Figure 55. Mexico Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 56. Brazil Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 57. Turkey Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 58. GCC Countries Antiviral Biomaterials Consumption and Growth Rate (2020-2031) & (K MT)

Figure 59. Global Production Market Share of Antiviral Biomaterials by Type (2020-2031)

Figure 60. Global Production Value Market Share of Antiviral Biomaterials by Type (2020-2031)

Figure 61. Global Antiviral Biomaterials Price (USD/MT) by Type (2020-2031)

Figure 62. Global Production Market Share of Antiviral Biomaterials by Application (2020-2031)

Figure 63. Global Production Value Market Share of Antiviral Biomaterials by Application (2020-2031)

Figure 64. Global Antiviral Biomaterials Price (USD/MT) by Application (2020-2031)

Figure 65. Antiviral Biomaterials Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions